-
ESTIMATINGTHE EFFECTS OF VARIED VACCINATION COVERAGE LEVELS ON A MEASLES OUTBREAK IN AN ISOLATED POPULATION
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA IN DEMENTIA RESEARCH: IMPLICATIONS FOR HEALTH ECONOMICS AND OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
COMPARING INFECTION OUTCOMES AND ANTIBIOTIC USE IN ADMINISTRATIVE CLAIMS FOLLOWING CYSTOURETHROSCOPY WITH SINGLE USE VERSUS REUSABLE SCOPES
Mar 18, 2026, 21:38 PM -
PATTERNS AND PREDICTORS OF LUNG CANCER CARE TRAJECTORIES: A SEQUENCE ANALYSIS OF INSURANCE CLAIMS
Mar 18, 2026, 21:38 PM -
GLOBAL AVAILABILITY AND ACCESS TO EVIDENCE-BASED ANTI-OBESITY PHARMACOTHERAPIES: A SYSTEMATIC ASSESSMENT OF REGULATORY AND REIMBURSEMENT LANDSCAPES
Mar 18, 2026, 21:38 PM -
THE TOTAL COST OF CARE AND BUDGET IMPACT OF INTRODUCING MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN FOR SECOND-LINE OR LATER (2L+) TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (LBCL) TO A UNITED STATES (US) HEALTH PLAN
Mar 18, 2026, 21:38 PM -
ACCESS TO INNOVATIVE AUTOIMMUNE THERAPIES IN LATIN AMERICA: CROSS-COUNTRY EVIDENCE TO INFORM VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING MODELS FOR PREDICTING SERIOUS ADVERSE EVENT REPORTS IN GLP-1 RECEPTOR AGONISTS USING FAERS, 2015-2025
Mar 18, 2026, 21:38 PM -
DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS
Mar 18, 2026, 21:38 PM -
BURDENOFHOSPITALACQUIREDPRESSURE INJURIES(HAPIS)AMONGST HIGH-RISK HOSPITALIZED PATIENTS:AREAL-WORLD ANALYSIS
Mar 18, 2026, 21:38 PM -
MODELLING ASSOCIATIONS BETWEEN EXTREME POVERTY TRAJECTORIES AND POPULATION GROWTH FOR HEALTH SYSTEMS PLANNING
Mar 18, 2026, 21:38 PM -
PRIORITIZING AND COSTING RMNCH INNOVATIONS FOR SCALABLE IMPACT: A COMBINED MCDA AND COSTING APPROACH FROM ETHIOPIA
Mar 18, 2026, 21:38 PM -
UPDATED COST-EFFECTIVENESS ANALYSIS OF POLATUZUMAB VEDOTIN COMBINED WITH CHEMOIMMUNOTHERAPY FOR UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN CHINA: EVIDENCE FROM LONG-TERM FOLLOW-UP OF THE POLARIX ASIAN SUBGROUP
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS ANALYSIS OF ADULT PNEUMOCOCCAL VACCINES INCLUDING PCV21 AND PCV20 TO OPTIMIZE NATIONAL IMMUNIZATION PROGRAM IN JAPAN
Mar 18, 2026, 21:38 PM -
A NOVEL BAYESIAN MODELING APPROACH INCREASES PRECISION OF PREDICTED LONG-TERM DURABILITY OF ETRANACOGENE DEZAPARVOVEC FOR THE TREATMENT OF HEMOPHILIA B
Mar 18, 2026, 21:38 PM -
DEVELOPING AND OPERATIONALIZING A SOCIETAL VALUE FRAMEWORK: A STYLIZED CASE STUDY IN ADVANCED HEPATOCELLULAR CARCINOMA
Mar 18, 2026, 21:38 PM -
FAST-TRACKING RARE DISEASES: USE OF FDA EXPEDITED PATHWAYS FOR ORPHAN DRUGS
Mar 18, 2026, 21:38 PM -
CAREGIVER-DEFINED UNMET NEEDS TO SUPPORT PATIENT-CENTERED TRIAL DESIGN AND VALUE CONSIDERATIONS IN MULTIPLE SULFATASE DEFICIENCY (MSD)
Mar 18, 2026, 21:38 PM -
PRICE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION
Mar 18, 2026, 21:38 PM -
STANDARDIZING AN ANNUAL REFERENCE COMPARATOR OF HEALTHCARE UTILIZATION OF PAINFUL DIABETIC NEUROPATHY (PDPN): A U.S. CLAIMS COHORT META-ANALYSIS FOR MODELING AND PAYER BENCHMARKING
Mar 18, 2026, 21:38 PM
